Medtronic PLC (MDT)


Common Stock Valuation Ratios (Price Multiples)
Quarterly Data

Difficulty: Beginner


Historical Valuation Ratios (Summary)

Medtronic PLC, historical price multiples (quarterly data)

Microsoft Excel LibreOffice Calc
Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014 Apr 25, 2014 Jan 24, 2014 Oct 25, 2013 Jul 26, 2013
Price to earnings (P/E) 32.75 28.78 25.11 57.38 41.16 37.80 37.82 21.55 26.35 29.96 28.24 23.20 32.64 33.17 43.49 47.09 37.49 40.56 24.45 24.86 20.97 20.75
Price to operating profit (P/OP) 22.21 21.26 19.74 21.13 20.04 17.64 16.73 17.82 19.53 22.64 21.53 18.18 22.35 22.18 25.45 26.74 25.83 28.81 19.66 20.15 16.87 16.68
Price to sales (P/S) 4.72 4.36 4.04 4.27 4.35 3.92 3.57 3.65 3.62 4.06 3.82 3.39 4.14 4.07 3.70 4.20 4.23 5.36 4.36 4.16 3.64 3.74
Price to book value (P/BV) 2.87 2.66 2.48 2.62 2.59 2.31 2.11 2.10 2.14 2.40 2.27 1.96 2.34 2.25 2.08 2.09 1.86 2.04 3.79 3.72 3.25 3.27 3.05 3.07 2.87

Based on: 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29), 10-K (filing date: 2014-06-20), 10-Q (filing date: 2014-03-03), 10-Q (filing date: 2013-12-03), 10-Q (filing date: 2013-09-04).

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Medtronic PLC’s P/E ratio increased from Q3 2019 to Q4 2019 and from Q4 2019 to Q1 2020.
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Medtronic PLC’s P/OP ratio increased from Q3 2019 to Q4 2019 and from Q4 2019 to Q1 2020.
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Medtronic PLC’s P/S ratio increased from Q3 2019 to Q4 2019 and from Q4 2019 to Q1 2020.
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company’s required rate of return and its actual rate of return. Medtronic PLC’s P/BV ratio increased from Q3 2019 to Q4 2019 and from Q4 2019 to Q1 2020.

Price to Earnings (P/E)

Medtronic PLC, historical P/E calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014 Apr 25, 2014 Jan 24, 2014 Oct 25, 2013 Jul 26, 2013
No. shares of common stock outstanding1 1,341,669,471 1,341,156,703 1,341,150,970 1,343,045,417 1,350,511,193 1,351,709,097 1,355,373,428 1,353,498,000 1,354,591,435 1,359,026,669 1,368,884,991 1,373,047,310 1,381,935,603 1,394,731,892 1,401,043,252 1,406,155,722 1,413,614,665 1,416,351,117 984,316,549 984,316,549 979,516,413 995,764,180 1,000,814,792 998,350,244 997,467,900
Selected Financial Data (US$)
Net income (loss) attributable to Medtronic (in millions) 864  1,172  1,269  1,115  1,075  1,460  (1,389) 2,017  1,016  1,163  821  1,115  929  1,103  1,095  520  820  (1) 977  828  871  448  762  902  953 
Earnings per share (EPS)2 3.29 3.45 3.67 1.68 2.34 2.30 2.07 3.71 3.04 2.96 2.90 3.09 2.64 2.54 1.74 1.65 1.86 1.89 3.17 2.96 3.05 3.08 0.00 0.00 0.00
Share price1, 3 107.89 99.38 92.09 96.60 96.41 86.81 78.33 79.87 80.05 88.79 81.86 71.67 86.15 84.14 75.55 77.56 69.59 76.61 77.59 73.48 63.85 63.86 59.04 57.64 53.20
Valuation Ratio
P/E ratio4 32.75 28.78 25.11 57.38 41.16 37.80 37.82 21.55 26.35 29.96 28.24 23.20 32.64 33.17 43.49 47.09 37.49 40.56 24.45 24.86 20.97 20.75
Benchmarks
P/E Ratio, Competitors5
Becton, Dickinson & Co. 83.38 66.87 72.88 408.36 105.60 206.04 49.63 59.56 30.05 28.94 36.65 32.09 43.18 41.64 45.52 38.75 27.56 24.05 22.89 23.01 23.08 22.82
Intuitive Surgical Inc. 51.02 53.16 53.03 73.32 73.33 69.50 70.95 45.87 42.21 38.18 37.16 36.58 39.90 37.79 34.24 34.20 40.55 40.41 44.77
Stryker Corp. 22.60 19.64 18.96 48.55 58.86 62.59 54.36 33.60 32.52 29.96 27.92 25.79 27.29 25.30 24.92 30.13 41.16 52.17 68.67
Thermo Fisher Scientific Inc. 31.08 35.11 35.19 36.71 39.27 37.52 37.66 33.39 30.36 30.83 30.45 29.02 31.09 29.03 26.19 26.44 28.23 29.27 27.26
UnitedHealth Group Inc. 17.98 17.93 21.09 21.18 20.91 20.02 20.77 23.90 23.24 22.18 21.73 20.76 22.06 20.88 18.18 18.15 18.97 18.21 18.50

Based on: 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29), 10-K (filing date: 2014-06-20), 10-Q (filing date: 2014-03-03), 10-Q (filing date: 2013-12-03), 10-Q (filing date: 2013-09-04).

1 Data adjusted for splits and stock dividends.

2 Q1 2020 Calculation
EPS = (Net income (loss) attributable to MedtronicQ1 2020 + Net income (loss) attributable to MedtronicQ4 2019 + Net income (loss) attributable to MedtronicQ3 2019 + Net income (loss) attributable to MedtronicQ2 2019) ÷ No. shares of common stock outstanding
= (864,000,000 + 1,172,000,000 + 1,269,000,000 + 1,115,000,000) ÷ 1,341,669,471 = 3.29

3 Closing price as at the filing date of Medtronic PLC’s Quarterly or Annual Report.

4 Q1 2020 Calculation
P/E ratio = Share price ÷ EPS
= 107.89 ÷ 3.29 = 32.75

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Medtronic PLC’s P/E ratio increased from Q3 2019 to Q4 2019 and from Q4 2019 to Q1 2020.

Price to Operating Profit (P/OP)

Medtronic PLC, historical P/OP calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014 Apr 25, 2014 Jan 24, 2014 Oct 25, 2013 Jul 26, 2013
No. shares of common stock outstanding1 1,341,669,471 1,341,156,703 1,341,150,970 1,343,045,417 1,350,511,193 1,351,709,097 1,355,373,428 1,353,498,000 1,354,591,435 1,359,026,669 1,368,884,991 1,373,047,310 1,381,935,603 1,394,731,892 1,401,043,252 1,406,155,722 1,413,614,665 1,416,351,117 984,316,549 984,316,549 979,516,413 995,764,180 1,000,814,792 998,350,244 997,467,900
Selected Financial Data (US$)
Operating profit (in millions) 1,485  1,946  1,542  1,544  1,236  1,935  1,426  1,901  1,389  1,631  1,147  1,385  1,167  1,505  1,355  1,300  1,131  373  1,275  1,030  1,088  491  980  1,149  1,193 
Operating profit per share2 4.86 4.67 4.67 4.57 4.81 4.92 4.68 4.48 4.10 3.92 3.80 3.94 3.85 3.79 2.97 2.90 2.69 2.66 3.95 3.65 3.79 3.83 0.00 0.00 0.00
Share price1, 3 107.89 99.38 92.09 96.60 96.41 86.81 78.33 79.87 80.05 88.79 81.86 71.67 86.15 84.14 75.55 77.56 69.59 76.61 77.59 73.48 63.85 63.86 59.04 57.64 53.20
Valuation Ratio
P/OP ratio4 22.21 21.26 19.74 21.13 20.04 17.64 16.73 17.82 19.53 22.64 21.53 18.18 22.35 22.18 25.45 26.74 25.83 28.81 19.66 20.15 16.87 16.68
Benchmarks
P/OP Ratio, Competitors5
Becton, Dickinson & Co. 29.43 29.40 30.27 43.37 47.87 95.72 67.53 34.59 40.06 21.15 20.05 25.02 22.42 27.98 26.60 29.46 26.74 19.97 17.53 16.89 17.51 17.69 17.27
Intuitive Surgical Inc. 49.12 51.89 49.87 48.90 50.69 46.82 44.40 41.74 35.53 31.07 28.93 28.50 31.46 30.10 27.24 27.43 31.35 30.80 34.42
Stryker Corp. 33.22 27.96 26.55 23.52 25.45 27.41 24.21 26.70 25.11 22.99 21.23 19.87 21.42 20.73 19.27 21.10 21.91 22.95 28.38
Thermo Fisher Scientific Inc. 24.59 28.45 27.33 26.24 28.33 26.99 28.24 28.12 25.79 26.21 25.13 24.26 25.78 24.44 22.15 22.84 23.53 24.03 20.63
UnitedHealth Group Inc. 12.51 12.48 14.58 15.82 15.19 14.17 14.42 14.30 13.54 12.56 11.79 11.14 11.71 11.07 9.59 9.79 10.34 9.95 10.12

Based on: 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29), 10-K (filing date: 2014-06-20), 10-Q (filing date: 2014-03-03), 10-Q (filing date: 2013-12-03), 10-Q (filing date: 2013-09-04).

1 Data adjusted for splits and stock dividends.

2 Q1 2020 Calculation
Operating profit per share = (Operating profitQ1 2020 + Operating profitQ4 2019 + Operating profitQ3 2019 + Operating profitQ2 2019) ÷ No. shares of common stock outstanding
= (1,485,000,000 + 1,946,000,000 + 1,542,000,000 + 1,544,000,000) ÷ 1,341,669,471 = 4.86

3 Closing price as at the filing date of Medtronic PLC’s Quarterly or Annual Report.

4 Q1 2020 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 107.89 ÷ 4.86 = 22.21

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Medtronic PLC’s P/OP ratio increased from Q3 2019 to Q4 2019 and from Q4 2019 to Q1 2020.

Price to Sales (P/S)

Medtronic PLC, historical P/S calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014 Apr 25, 2014 Jan 24, 2014 Oct 25, 2013 Jul 26, 2013
No. shares of common stock outstanding1 1,341,669,471 1,341,156,703 1,341,150,970 1,343,045,417 1,350,511,193 1,351,709,097 1,355,373,428 1,353,498,000 1,354,591,435 1,359,026,669 1,368,884,991 1,373,047,310 1,381,935,603 1,394,731,892 1,401,043,252 1,406,155,722 1,413,614,665 1,416,351,117 984,316,549 984,316,549 979,516,413 995,764,180 1,000,814,792 998,350,244 997,467,900
Selected Financial Data (US$)
Net sales (in millions) 7,493  8,146  7,546  7,481  7,384  8,144  7,369  7,050  7,390  7,916  7,283  7,345  7,166  7,567  6,934  7,058  7,274  7,304  4,318  4,366  4,273  4,565  4,163  4,194  4,083 
Sales per share2 22.86 22.78 22.78 22.62 22.17 22.16 21.93 21.90 22.10 21.86 21.45 21.13 20.79 20.67 20.39 18.46 16.46 14.31 17.80 17.64 17.55 17.08 0.00 0.00 0.00
Share price1, 3 107.89 99.38 92.09 96.60 96.41 86.81 78.33 79.87 80.05 88.79 81.86 71.67 86.15 84.14 75.55 77.56 69.59 76.61 77.59 73.48 63.85 63.86 59.04 57.64 53.20
Valuation Ratio
P/S ratio4 4.72 4.36 4.04 4.27 4.35 3.92 3.57 3.65 3.62 4.06 3.82 3.39 4.14 4.07 3.70 4.20 4.23 5.36 4.36 4.16 3.64 3.74
Benchmarks
P/S Ratio, Competitors5
Becton, Dickinson & Co. 3.82 3.64 3.82 4.06 4.45 4.49 4.94 4.23 3.72 3.21 3.05 2.87 2.97 2.86 2.55 3.08 3.35 3.51 3.26 3.21 2.69 2.66 2.62
Intuitive Surgical Inc. 15.28 15.83 16.06 16.36 17.01 16.16 14.96 13.83 12.01 10.69 10.11 10.06 10.69 9.70 8.46 8.07 8.96 8.66 8.80
Stryker Corp. 5.65 4.98 4.95 4.52 4.88 5.01 4.46 4.93 4.62 4.29 4.06 3.93 4.18 4.07 3.61 3.60 3.91 3.58 3.66
Thermo Fisher Scientific Inc. 4.43 4.52 4.24 3.95 4.07 3.84 4.01 3.92 3.58 3.57 3.37 3.22 3.53 3.34 3.05 3.11 3.30 3.01 3.06
UnitedHealth Group Inc. 1.00 0.98 1.12 1.22 1.17 1.09 1.10 1.05 0.98 0.89 0.83 0.75 0.78 0.76 0.68 0.76 0.84 0.81 0.80

Based on: 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29), 10-K (filing date: 2014-06-20), 10-Q (filing date: 2014-03-03), 10-Q (filing date: 2013-12-03), 10-Q (filing date: 2013-09-04).

1 Data adjusted for splits and stock dividends.

2 Q1 2020 Calculation
Sales per share = (Net salesQ1 2020 + Net salesQ4 2019 + Net salesQ3 2019 + Net salesQ2 2019) ÷ No. shares of common stock outstanding
= (7,493,000,000 + 8,146,000,000 + 7,546,000,000 + 7,481,000,000) ÷ 1,341,669,471 = 22.86

3 Closing price as at the filing date of Medtronic PLC’s Quarterly or Annual Report.

4 Q1 2020 Calculation
P/S ratio = Share price ÷ Sales per share
= 107.89 ÷ 22.86 = 4.72

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Medtronic PLC’s P/S ratio increased from Q3 2019 to Q4 2019 and from Q4 2019 to Q1 2020.

Price to Book Value (P/BV)

Medtronic PLC, historical P/BV calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014 Apr 25, 2014 Jan 24, 2014 Oct 25, 2013 Jul 26, 2013
No. shares of common stock outstanding1 1,341,669,471 1,341,156,703 1,341,150,970 1,343,045,417 1,350,511,193 1,351,709,097 1,355,373,428 1,353,498,000 1,354,591,435 1,359,026,669 1,368,884,991 1,373,047,310 1,381,935,603 1,394,731,892 1,401,043,252 1,406,155,722 1,413,614,665 1,416,351,117 984,316,549 984,316,549 979,516,413 995,764,180 1,000,814,792 998,350,244 997,467,900
Selected Financial Data (US$)
Shareholders’ equity (in millions) 50,363  50,091  49,829  49,607  50,224  50,720  50,234  51,469  50,672  50,294  49,387  50,186  50,824  52,063  50,816  52,269  52,809  53,230  20,173  19,438  19,248  19,443  19,354  18,744  18,519 
Book value per share (BVPS)2 37.54 37.35 37.15 36.94 37.19 37.52 37.06 38.03 37.41 37.01 36.08 36.55 36.78 37.33 36.27 37.17 37.36 37.58 20.49 19.75 19.65 19.53 19.34 18.77 18.57
Share price1, 3 107.89 99.38 92.09 96.60 96.41 86.81 78.33 79.87 80.05 88.79 81.86 71.67 86.15 84.14 75.55 77.56 69.59 76.61 77.59 73.48 63.85 63.86 59.04 57.64 53.20
Valuation Ratio
P/BV ratio4 2.87 2.66 2.48 2.62 2.59 2.31 2.11 2.10 2.14 2.40 2.27 1.96 2.34 2.25 2.08 2.09 1.86 2.04 3.79 3.72 3.25 3.27 3.05 3.07 2.87
Benchmarks
P/BV Ratio, Competitors5
Becton, Dickinson & Co. 3.04 2.91 3.05 3.09 3.07 2.87 2.85 3.95 3.60 4.96 4.99 4.69 4.55 4.56 3.97 4.42 4.35 4.15 5.46 5.37 4.17 4.13 4.22
Intuitive Surgical Inc. 8.49 8.68 8.96 9.30 10.03 9.71 9.91 8.35 7.62 7.21 4.73 4.77 5.22 5.00 4.67 4.53 5.37 5.31 5.55 5.71 6.03 3.85
Stryker Corp. 6.72 5.92 5.74 6.09 6.72 6.92 5.56 5.73 5.51 5.21 4.82 4.59 4.81 4.65 4.21 4.18 4.52 4.19 4.11 3.66 3.40 3.26
Thermo Fisher Scientific Inc. 3.83 4.02 3.75 3.51 3.55 3.24 3.30 3.14 3.07 3.07 2.86 2.67 2.92 2.76 2.42 2.50 2.69 2.55 2.51 2.29 2.35 2.23
UnitedHealth Group Inc. 4.40 4.37 4.89 5.32 5.13 4.72 4.59 4.55 4.37 4.01 3.98 3.61 3.75 3.57 3.12 3.35 3.51 3.39 3.20 2.79 2.43 2.27

Based on: 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29), 10-K (filing date: 2014-06-20), 10-Q (filing date: 2014-03-03), 10-Q (filing date: 2013-12-03), 10-Q (filing date: 2013-09-04).

1 Data adjusted for splits and stock dividends.

2 Q1 2020 Calculation
BVPS = Shareholders’ equity ÷ No. shares of common stock outstanding
= 50,363,000,000 ÷ 1,341,669,471 = 37.54

3 Closing price as at the filing date of Medtronic PLC’s Quarterly or Annual Report.

4 Q1 2020 Calculation
P/BV ratio = Share price ÷ BVPS
= 107.89 ÷ 37.54 = 2.87

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company’s required rate of return and its actual rate of return. Medtronic PLC’s P/BV ratio increased from Q3 2019 to Q4 2019 and from Q4 2019 to Q1 2020.